| 缩写名/全名 |
HUM GENE THER CL DEV
Human Gene Therapy Clinical Development |
||||||||||||||||
| ISSN号 | 2324-8637 | ||||||||||||||||
| 研究方向 | CRITICAL CARE MEDICINEMEDICINE, RESEARCH &-MEDICINE, RESEARCH & EXPERIMENTAL | ||||||||||||||||
| 影响因子 | 2015:2.889, 2016:2.49, 2017:2.431, 2018:2.778, 2019:3.611, | ||||||||||||||||
| 出版国家 | UNITED STATES | ||||||||||||||||
| 出版周期 | |||||||||||||||||
| 年文章数 | 15 | ||||||||||||||||
| 出版年份 | 0 | ||||||||||||||||
| 是否OA | No | ||||||||||||||||
| 审稿周期(仅供参考) | |||||||||||||||||
| 录用比例 | |||||||||||||||||
| 投稿链接 | http://www.liebertpub.com/forauthors/human-gene-therapy/19/ | ||||||||||||||||
| 投稿官网 | http://online.liebertpub.com/humc | ||||||||||||||||
| h-index | 16 | ||||||||||||||||
| CiteScore |
|
||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2324-8637%5BISSN%5D | ||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | In Vitro and Clinical Studies of Gene Therapy with Recombinant Human Adenovirus-p53 Injection for Malignant Melanoma. Author: Shi SW1,2, Li B1, Dong Y1, Ge Y1, Qu X1, Lu LG1, Yuan YH1, Li LJ1, Li Y1. Journal: Hum Gene Ther Clin Dev. 2019 Mar;30(1):7-18. doi: 10.1089/humc.2018.112. Epub 2019 Jan 31. PubMed DOI |
| 2. | Knockdown of LINC02465 Suppresses Gastric Cancer Cell Growth and Metastasis Via PI3K/AKT Pathway. Author: Han L1, Hao Y1, Wang J1, Wang Z1, Yang H1, Wu X1. Journal: Hum Gene Ther Clin Dev. 2019 Mar;30(1):19-28. doi: 10.1089/humc.2018.177. Epub 2019 Feb 7. PubMed DOI |
| 3. | Upregulation of DNA Metabolism-Related Genes Contributes to Radioresistance of Glioblastoma. Author: Wang C1, Zheng W1, Yao D1, Chen Q1, Zhu L1, Zhang J1, Pan Y1, Zhang J1, Shao C1. Journal: Hum Gene Ther Clin Dev. 2019 Mar 11. doi: 10.1089/humc.2018.251. [Epub ahead of print] PubMed DOI |
| 4. | LncRNA HOXA-AS3 Sponges miR-29c to Facilitate Cell Proliferation, Metastasis, and EMT Process and Activate the MEK/ERK Signaling Pathway in Hepatocellular Carcinoma. Author: Tong Y1, Wang M1, Dai Y1, Bao D1, Zhang J1, Pan H1. Journal: Hum Gene Ther Clin Dev. 2019 May 17. doi: 10.1089/humc.2018.266. [Epub ahead of print] PubMed DOI |
| 5. | miR-632 Functions as Oncogene in Hepatocellular Carcinoma via Targeting MYCT1. Author: Pu J1, Wang J1, Xu Z2, Lu Y2, Wu X2, Wu Y2, Shao Z2, Tang Q3, Wei H4. Journal: Hum Gene Ther Clin Dev. 2019 May 8. doi: 10.1089/humc.2019.040. [Epub ahead of print] PubMed DOI |
|
